$XALL: Xalles Plans to Implement AI Tools to Optimize the

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
139
$XALL: Xalles Plans to Implement AI Tools to Optimize the Fintech Ecosystem
Click here:
https://finance.yahoo.com/news/xalles-establi...00666.html

February 22, 2022 (Globe Newswire)
viaNewMediaWire - Xalles Holdings Inc. (OTC: XALL), a fintech holding company providing innovative technology and financial services solutions, today announces that Xalles Technology it has executed a marketing agreement with Salesmaster ai to refer clients to implement an innovative suite of sales and marketing artificial intelligence services.

Xalles Technology Inc., a wholly owned subsidiary of Xalles Holdings Inc., and Salesmaster ai, a Florida-based artificial intelligence company, will work together to implement sales and marketing AI solutions for Xalles clients and prospects, within the financial services industry and within other vertical markets. The existing solutions available include using AI in real-time for digital advertising without the use of cookies or data retention, lead generation and more through an AI-driven 'Infrastructure as a Solution'.

"The Xalles management team believes that artificial intelligence is the next major long-term trend in system solutions that will support improving a wide variety of processes," stated Thomas Nash, Chairman and CEO of Xalles Holdings Inc. He continued, "We think our AI philosophy and goals are well aligned with Salesmaster ai and we plan to work together to support their existing solutions and develop new AI tools."

"Salesmaster ai is pleased to be partnered with Xalles and utilize their network to reach more growth-oriented clients," commented Arturo Del Rio Jr., CEO of Salesmaster ai. He added, "Our AI-based platform has generated terrific returns and cost savings to clients, fueling their ambition for growth."

About Xalles Holdings Inc.

Xalles Holdings Inc. is a holding company that focuses on the acquisition, alignment, and growth of disruptive fintech companies. The company actively seeks targets in which it can acquire and accelerate market expansion, targeting companies with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities. The company places emphasis on leveraging blockchain technologies to provide industry-leading financial solutions, which, over time, will allow for the capture of recurring revenue streams. For more information, visit our website at www.xalles.com.

About Salesmaster ai

Salesmaster ai is a 100% remote, global company, all connected through modern technology, our human-powered, AI-driven 'Infrastructure as a Solution' helps committed partners make the impact they've always envisioned. The growth process is simplified and optimized through the power of our AI-driven infrastructure and all-in-one platform. Salesmaster ai will help you to thrive. Our suite of AI Growth Tools will make that a reality by systematizing the entire, end-to-end sales and marketing process. For more information, visit our website at www.salesmaster.ai

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov and in OTC Markets at www.otcmarkets.com.

Investor Relations Contacts:

info@xalles.com

202.595.1299 Office
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 256

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 68

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 194

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 20

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading

Top 5 Most Recently Viewed Articles

Academy Sports + Outdoors Teams Up to Empower Military Families

Updated Category News Views 142

Academy Sports + Outdoors Supports Military Families This School Year In an inspiring initiative aimed at supporting military families, Academy Sports + Outdoors has partnered with Operation Homefront to provide essential school supplies for students heading back to class. As the back-to-school season approaches, these organizations are ensuring that military children...

Continue Reading
Repligen Corp's Q4 Earnings Reflect Strong Market Momentum

Updated Category News Views 232

Repligen Corp Highlights Strong Q4 Performance Repligen Corp (NASDAQ: RGEN) has recently reported its fourth-quarter earnings, showcasing an adjusted EPS of 44 cents. This is a slight decrease compared to the previous year's 48 cents but notably beats analysts’ consensus estimates of 41 cents. Sales Performance and Market Outlook The company reported sales hitting...

Continue Reading
Propanc Biopharma's Fiscal Year Highlights and Future Plans

Updated Category News Views 130

Propanc Biopharma's Recent Developments and Strategic Vision Propanc Biopharma, Inc. (NASDAQ: PPCB), a biopharmaceutical firm centered on innovations in cancer treatment, recently shared its year-end updates and strategic plans. As the financial year concluded on June 30, 2025, notable gains in the Company’s financial health have paved the way for exciting advancements....

Continue Reading
MIAX Strengthens Leadership with Key Executive Appointments

Updated Category News Views 253

MIAX Expands Leadership Team to Drive Market Growth Miami International Holdings, Inc. (NYSE: MIAX) is excited to unveil the new appointments of Shelly Brown and Joseph W. Ferraro III as part of its commitment to strategic growth in the futures market. These moves are aimed at enhancing leadership within MIAX Futures™, a core component of its expanding offerings in...

Continue Reading
Fortis Inc. Declares Upcoming Dividends for Shareholders

Updated Category News Views 137

Fortis Inc. Announces Upcoming Shareholder Dividends Fortis Inc. has officially declared dividends that are set to benefit its shareholders on March 1, 2025. This announcement is a key development for shareholders holding various classes of shares with specific dividends attached. The established record date for these dividends is February 18, 2025, marking an important...

Continue Reading